FMWA
MDXG icon

Forvis Mazars Wealth Advisors’s MiMedx Group MDXG Stock Holding History

Forvis Mazars Wealth Advisors’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-25,305
Closed -$184K – 394
2023
Q3 		$184K Buy
25,305
+1,715
+7% +$12.8K 0.01% 379
2023
Q2 		$156K Sell
23,590
-2,015
-8% -$10.3K ﹤0.01% 400
2023
Q1 		$87.3K Hold
25,605
– – ﹤0.01% 405
2022
Q4 		$71.2K Sell
25,605
-2,985
-10% -$8.92K ﹤0.01% 386
2022
Q3 		$82K Hold
28,590
– – ﹤0.01% 382
2022
Q2 		$99K Buy
+28,590
New +$112K ﹤0.01% 385

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Forvis Mazars Wealth Advisors's MDXG Position: Q4 2023 in Review

Forvis Mazars Wealth Advisors sold out of MiMedx Group (MDXG) in Q4 2023, closing a stake of 25,305 shares — an estimated $184K sold.

Forvis Mazars Wealth Advisors first reported a position in MDXG in Q2 2022 and held it in 6 quarters. The position peaked at $184K in Q3 2023. 199 funds tracked by Wall St. Rank hold MDXG as of Q4 2023.

  • Forvis Mazars Wealth Advisors reported no remaining MiMedx Group position as of Q4 2023 after selling out during the quarter.
  • Forvis Mazars Wealth Advisors sold 25,305 MiMedx Group shares in Q4 2023, an estimated $184K.
  • Forvis Mazars Wealth Advisors first reported a position in MiMedx Group in Q2 2022 and held it in 6 quarters.
  • Forvis Mazars Wealth Advisors's MiMedx Group position peaked at $184K in Q3 2023.
  • 199 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2023.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q4 2023, filed 11 Jan 2024.